Biotech / Medical
Novavax NVAX
An SI Board Since March 2002
Posts SubjectMarks Bans Symbol
79 9 0 NVAX
Emcee:  Jack Hartmann Type:  Moderated
Novavax is rising $1.21, or 11.5 percent, to $11.70, after the Los Angeles biopharmaceutical firm reported positive results of a phase III trial of Estrasorb, its experimental treatment for vasomotor symptoms, or hot flashes, in postmenopausal women. The company said that patients using Estrasorb in the randomized, double-blind trial experienced an 85 percent reduction in the total number of hot flashes during the course of the trial. Novavax also said that about half of the patients reported complete cessation of hot flashes during a 7-day period by week 10 of the treatment. Fewer than 10 percent of the patients in the placebo group noticed a similar improvement.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
79This company is facing difficult time, high cash burn, not much money left, leadmore100-9/16/2016
78More dilution for NVAX: <b>Novavax Prices Public Offering of Common StockGlenn Petersen-11/20/2009
77Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing tnsaf-10/29/2009
76<b>Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu VaccGlenn Petersen-10/20/2009
75NVAX is moving higher in pre-market trading, in what would appear to be an over-Glenn Petersen-10/13/2009
74<b>Developing A Better Vaccine</b> Tevi Troy Forbes Magazine 09.27.Glenn Petersen-9/28/2009
73<b>Form 8-K for NOVAVAX INC</b> 15-Sep-2009 Entry into a Material Glenn Petersen-9/16/2009
72I have always had problems with the egg based vaccines-----I have stopped gettinMJ-9/9/2009
71Novartis looking at Novavax - Rumor on MSN Rumor Roundup With the market openinRock_nj-9/9/2009
70Novavax's vaccine is safer than the egg-based vaccines. One of the reasons Rock_nj-9/9/2009
69Letter to Readers Notice to Neurologists on Influenza A (H1N1) Virus VaccinatioMJ-9/8/2009
68Novavax in talks with "half dozen" countries-CEO Tue Sep 8, 2009 2:01pRock_nj-9/8/2009
67I don't. Some of those fools were unloading their NVAX holdings back in JunRock_nj-9/8/2009
66Do we pay attention to the analysts who tout the stock for the big mutual funds?Michael Young-9/7/2009
65Novavax's VLP Technology Is a Game Changer by: M. E. Garza September 07, 20Rock_nj-9/7/2009
64That harsh reality is hitting home, with the media in India criticizing the goveRock_nj-9/4/2009
63China set to approve 1-dose swine flu vaccines L Comiskey-9/2/2009
62Novavax, Inc. To Apply For H1N1 Vaccine Trials In Fourth Quarter-Reuters TuesdaRock_nj-9/2/2009
61<b>Swine Flu Could Infect Half of U.S. Presidential Panel's Estimate Glenn Petersen-9/1/2009
60A good morning for NVAX: <b>NOVAVAX Announces Positive Results for the SeGlenn Petersen-9/1/2009
59This could help Novavax: Anticipated H1N1 Vaccine Shortage Has U.S. Officials SRock_nj-8/18/2009
58Cadila Pharma plans swine flu vaccine by November Nimish Shukla , TNN 11 August Rock_nj-8/11/2009
57Cadila Pharma to produce swine flu vaccine (with Novavax) TNN 10 August 2009, 06Rock_nj-8/10/2009
56Novavax quarterly report and conference call are tomorrow. I think we might getRock_nj-8/5/2009
55NVAX (<span style='font-size:11px'>LAST</span>:<b> 4.6Glenn Petersen-8/5/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.